« « Don't Diet Alone…Join Calorie Count Plus Groups 
|  Older Diabetics With Depression Face Higher Death Rate - Washington Post » »
UPDATE 1-Takeda: FDA won't finish diabetes drug review on time - Reuters
Saturday, October 11th, 2008    Subscribe To Our FeedNetwork Médica |
UPDATE 1-Takeda: FDA won't finish diabetes drug review on time
Reuters?- 22 hours ago The drug, called alogliptin or SYR-322, is critical to Takeda's mainstay diabetes business as it is expected to be the main replacement for its best-selling … Diabetes Drug FDA Review Not on Schedule Due to Lack of Resources … Network Médica PPD's payment from Takeda hung up by FDA delay StarNewsOnline.com FDA Continues Review of Takeda's New Drug Application for … MarketWatch Forbes?- Bizjournals.com all 47 news articles |
Source:UPDATE 1-Takeda: FDA won't finish diabetes drug review on time - Reuters
No Tags
Like this post? Publish It On Your Own Blog
Posted in insulin | | Top Of Page
Site Search Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags
Possible Related Posts
Takeda's Actos prevents diabetes, study finds - ReutersUPDATE 1-Elixir Pharma's oral diabetes drug meets trial goal - ReutersUPDATE 1-Roche, Ipsen launch pivotal trial of diabetes drug - Reuters





















